Metraipolis › archive › dc_ad1be0705e72

MDM2-amplified esophageal adenocarcinomas exhibit an activated metabolic and immunosuppressive phenotype with multiple potential therapeutic targets — Europe PMC PMID:41299419

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41299419
DOI
10.1186/s12885-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-11-08T06:08:17.054Z
SHA-256 of the archived text
76a3827ed00340e7ee42435bfaa533abc58d0a86444eeef61df08b6e4d86532f
Stable URL of this page
https://metraipolis.com/documento/dc_ad1be0705e72

How to cite

MDM2-amplified esophageal adenocarcinomas exhibit an activated metabolic and immunosuppressive phenotype with multiple potential therapeutic targets — Europe PMC PMID:41299419 — Europe PMC (en), https://europepmc.org/article/MED/41299419 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ad1be0705e72 (Metraipolis archive dc_ad1be0705e72, sha256 76a3827ed00340e7ee42435bfaa533abc58d0a86444eeef61df08b6e4d86532f)
BibTeX
@misc{dcad1be0705e72,
  title = {MDM2-amplified esophageal adenocarcinomas exhibit an activated metabolic and immunosuppressive phenotype with multiple potential therapeutic targets — Europe PMC PMID:41299419},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41299419},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ad1be0705e72; sha256 76a3827ed00340e7ee42435bfaa533abc58d0a86444eeef61df08b6e4d86532f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41299419. Agents can read the archived copy with the MCP tool read_document.